首页> 外文期刊>中国癌症研究(英文版) >Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling
【24h】

Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling

机译:过氧甲酸(6-十五烷基水杨酸)通过抑制雄激素受体和激活p53信号来诱导前列腺癌细胞的凋亡

获取原文
获取原文并翻译 | 示例
       

摘要

Anacardic acid (AA) is a mixture of 2-hydroxy-6-alkylbenzoic acid homologs.It is widely regarded as a non-specific histone acetyltransferase inhibitor of p300.The effects and the mechanisms of AA in LNCaP cells (prostate cancer cells) remain unknown.To investigate the effect of AA on LNCaP cells,we had carried out several experiments and found that AA inhibits LNCaP cell proliferation,induces G1/S cell cycle arrest and apoptosis of LNCaP cell.The mechanisms via which AA acts on LNCaP cells may be due to the following aspects.First,AA can regulate p300 transcription and protein level except for its mechanisms regulating function of p300 through post-translational modification in LNCaP cells.Second,AA can activate p53 through increasing the phosphorylation of p53 on Ser15 in LNCaP cells.AA can selectively activate p21 (target genes of p53).Third,AA can down-regulates androgen receptor (AR) through supressing p300.Our study suggests that AA has multiple anti-tumor activities in LNCaP cells and warrants further investigation.
机译:Anacardic acid(AA)是2-羟基-6-烷基苯甲酸同系物的混合物,被广泛认为是p300的非特异性组蛋白乙酰转移酶抑制剂,AA在LNCaP细胞(前列腺癌细胞)中的作用和机制仍然存在为了研究AA对LNCaP细胞的影响,我们进行了一些实验,发现AA抑制LNCaP细胞增殖,诱导G1 / S细胞周期阻滞和LNCaP细胞凋亡。AA作用于LNCaP细胞的机制可能是未知的。首先,AA可以通过调节LNCaP细胞的翻译后修饰来调节p300的功能,而可以调节p300的转录和蛋白质水平。其次,AA可以通过增加LNCaP中Ser15上p53的磷酸化来激活p53。氨基酸可以选择性激活p21(p53的靶基因)。第三,氨基酸可以通过抑制p300来下调雄激素受体(AR)。我们的研究表明,AA在LNCaP细胞中具有多种抗肿瘤活性。并保证进一步调查。

著录项

  • 来源
    《中国癌症研究(英文版)》 |2012年第4期|275-283|共9页
  • 作者单位

    Department of Urology, the third Xiangya Hospital of Xiangya Medical College, Central South University, Changsha 410013, China;

    Department of Urology, the third Xiangya Hospital of Xiangya Medical College, Central South University, Changsha 410013, China;

    Department of Urology, the third Xiangya Hospital of Xiangya Medical College, Central South University, Changsha 410013, China;

    Department of Urology, the third Xiangya Hospital of Xiangya Medical College, Central South University, Changsha 410013, China;

    Department of Urology, the third Xiangya Hospital of Xiangya Medical College, Central South University, Changsha 410013, China;

    Department of Urology, the third Xiangya Hospital of Xiangya Medical College, Central South University, Changsha 410013, China;

    Department of Urology, the third Xiangya Hospital of Xiangya Medical College, Central South University, Changsha 410013, China;

    Department of Urology, the third Xiangya Hospital of Xiangya Medical College, Central South University, Changsha 410013, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号